166 related articles for article (PubMed ID: 14703197)
21. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
22. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
23. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
24. Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study.
Toprak A; Koc M; Tezcan H; Ozener IC; Akoglu E; Oktay A
Nephrol Dial Transplant; 2003 Oct; 18(10):2128-33. PubMed ID: 13679491
[TBL] [Abstract][Full Text] [Related]
25. Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis.
Merlino G; Lorenzut S; Romano G; Sommaro M; Fontana A; Montanaro D; Valente M; Gigli GL
Neurol Sci; 2012 Dec; 33(6):1311-8. PubMed ID: 22271263
[TBL] [Abstract][Full Text] [Related]
26. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET
Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Cardiac Outcome of Continuous Ambulatory Peritoneal Dialysis & Hemodialysis in CKD5 Patients with Heart Failure.
Barman TK; Roy S; Hossain SM; Salahuddin AZ; Huq MO
Mymensingh Med J; 2020 Oct; 29(4):793-799. PubMed ID: 33116079
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
29. Association of Intradialytic Hypertension with Left Ventricular Mass in Hypertensive Hemodialysis Patients Enrolled in the Blood Pressure in Dialysis (BID) Study.
Shamir AR; Karembelkar A; Yabes J; Yao Y; Miskulin D; Gassman J; Ploth D; Negrea L; Paine S; Rahman M; Kwong RY; Zager P; Jhamb M
Kidney Blood Press Res; 2018; 43(3):882-892. PubMed ID: 29870977
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD
Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
[TBL] [Abstract][Full Text] [Related]
31. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
32. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
[TBL] [Abstract][Full Text] [Related]
33. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
34. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
[TBL] [Abstract][Full Text] [Related]
35. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
[TBL] [Abstract][Full Text] [Related]
36. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
Kim DH; Yang DH; Hong SY
Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
[TBL] [Abstract][Full Text] [Related]
38. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.
Alvestrand A; Ledebo I; Hagerman I; Wingren K; Mattsson E; Qureshi AR; Gutierrez A
Blood Purif; 2011; 32(1):21-9. PubMed ID: 21252503
[TBL] [Abstract][Full Text] [Related]
39. Pruritus in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Balaskas EV; Chu M; Uldall RP; Gupta A; Oreopoulos DG
Perit Dial Int; 1993; 13 Suppl 2():S527-32. PubMed ID: 8399656
[TBL] [Abstract][Full Text] [Related]
40. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
